Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

The FDA launched Elsa, its first generative AI tool, to streamline reviews and modernize agency workflow across all centers.

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...

The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency ...

The FDA introduced Elsa, an artificial intelligence (AI) tool intended to enhance efficiency in clinical reviews and ...

FDA announced the launch of Elsa, a generative AI tool designed to “help employees—from scientific reviewers to ...